Skip to content

Clinical study on the multi-center randomized controlled optimization scheme of Shugan Tiaoshen integrated acupuncture in the treatment of moderate depressive disorder

Clinical study on the multi-center randomized controlled optimization scheme of Shugan Tiaoshen integrated acupuncture in the treatment of moderate depressive disorder

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004326
Enrollment
Unknown
Registered
2021-01-27
Start date
2021-03-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of Chinese and Western medicine; 2. Age 18 ~ 65 years old, junior high school (including) or above; 3. The 17 Hamilton Depression Scale (HAMD-17) scores were > 17 and <= 24; 4. Signed the informed consent and volunteered to participate in the study. Only those who meet the above four criteria can be included in the study.

Exclusion criteria

Exclusion criteria: 1. People with suicidal tendencies; 2. Previous diagnosis of mental disorders, schizophrenia, bipolar disorder, substance abuse (such as: alcohol dependence) or other mental disorders; 3. Epileptic seizure history or strong positive family history of epilepsy, brain organic disease and severe physical disease; 4. Taking antidepressant drugs within 6 weeks (including 6 weeks); 5. Pregnancy, pregnancy preparation or lactation; 6. Patients with skin lesions or skin diseases, severe diabetes mellitus, tumors, insufficiency of important organs or serious internal diseases such as liver, kidney, cardiovascular, endocrine, respiratory system and hematopoietic system; Those who meet any of the above criteria will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
HAMD-17;

Secondary

MeasureTime frame
HAMA;Body motion records data;Pittsburgh sleep quali-ty index;

Countries

China

Contacts

Public ContactWenbin Fu

Guangdong Provincial Hospital of Traditional Chinese Medicine

fuwenbin@139.com+86 13808888626

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026